DJIA 17,122.01 15.31 0.09%
NASDAQ 4,569.62 -1.02 -0.02%
S&P 500 2,000.12 0.10 0.00%
market minute promo

4.22 -0.03 (-0.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARNA $4.22 -0.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.25
Previous Close $4.25
Daily Range $4.20 - $4.28
52-Week Range $4.05 - $7.97
Market Cap $927.7M
P/E Ratio -16.35
Dividend (Yield) $0.00 (0.0%)
Volume 3,028,808
Average Daily Volume 4,619,366
Current FY EPS -$0.35

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary Rss Feed

Biotech Investing: 3 Ways You're Doing It Wrong

Biotech investing might appear easy considering some of the big gains we've witnessed in recent years, but these three common mistakes make it very difficult for the average biotech investor to make money.

Advertising And The Belviq Re-Launch

Belviq Sales Rise 2%

Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind

MannKind Corp. And The Folly Of Cult Biotech Stocks

Arena And VIVUS: A Case Study In Small-Cap Pharma

Belviq Sales Flatten Out But Edge Above Qsymia

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another

Arena's Belviq Bucks Seasonality With 3.6% Week Over Week Gain

Vivus Beats The Street - Still Has A Loss

See More ARNA News...

ARNA's Top Competitors

ARNA $4.22 (-0.71%)
Current stock: ARNA
AMGN $137.83 (0.41%)
Current stock: AMGN
GILD $107.41 (1.07%)
Current stock: GILD
BIIB $343.36 (0.11%)
Current stock: BIIB